Parallel Advisors, LLC

Position in PCVX — Vaxcyte, Inc.

CIK 1690010 SAN FRANCISCO, CA

Position in PCVX

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$131,373

+$32,935 QoQ

Shares Held

2,260

+33.4% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#233

of 329 holders

Holding Since

Sep 2021

17 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Parallel Advisors, LLC holds $359,916,636 across 168 Biotechnology names. PCVX ranks #28 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CORT	Corcept Therapeutics Inc	3,962,177	$344,511,290
2	VRTX	Vertex Pharmaceuticals Inc / Ma	5,389	$2,676,877
3	RCUS	Arcus Biosciences, Inc.	86,557	$2,668,552
4	REGN	Regeneron Pharmaceuticals, Inc.	1,063	$662,823
5	KRYS	Krystal Biotech, Inc.	1,699	$631,467
6	ARGX	Argenx SE	640	$593,772
7	INCY	Incyte Corp	4,961	$562,378
8	VKTX	Viking Therapeutics, Inc.	13,833	$539,625

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$131,373	2,260	+33.4%	Shares	Sole	2026-08-05
2026-03-31	$98,438	1,694	+189.1%	Shares	Sole	2026-05-07
2025-12-31	$27,038	586	-50.3%	Shares	Sole	2026-02-11
2025-09-30	$42,503	1,180	-38.2%	Shares	Sole	2025-11-13
2025-06-30	$62,061	1,909	+19.5%	Shares	Sole	2025-07-08
2025-03-31	$60,302	1,597	+203.6%	Shares	Sole	2025-04-08
2024-12-31	$43,058	526	+1.7%	Shares	Sole	2025-02-10
2024-09-30	$59,077	517	+10.7%	Shares	Sole	2024-11-13
2024-06-30	$35,263	467	+3.1%	Shares	Sole	2024-08-08
2024-03-31	$30,944	453	+10.2%	Shares	Sole	2024-05-06
2023-12-31	$25,810	411	+155.3%	Shares	Sole	2024-02-12
2023-09-30	$8,207	161	+666.7%	Shares	Sole	2024-05-20
2023-06-30	$1,048	21	0.0%	Shares	Sole	2024-05-20
2023-03-31	$787	21	-22.2%	Shares	Sole	2024-05-20
2022-12-31	$1,294	27	+145.5%	Shares	Sole	2023-02-06
2022-09-30	$264	11	-60.7%	Shares	Sole	2022-11-10
2021-09-30	$710	28	—	Shares	Sole	2021-11-02
No filing history on record for this holder in this stock.